Concepedia

Julie Borland

JB

43

Publications

2.3K

Citations

28

H-Index

1993

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Harefield Hospital

Shionogi (Japan)

Hammersmith Hospital

Julie Borland is an author at GlaxoSmithKline (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1993–2016

43

Publications

43

Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers

Sherene Min, Ivy Song, Julie Borland et al. · Antimicrobial Agents and Chemotherapy · 2009 · 239 citations · Full text

Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin

Kelly E. Dooley, Patrick Sayre, Julie Borland et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2012 · 191 citations

A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para‐aminohippurate clearance in healthy subjects

Justin Koteff, Julie Borland, Shuguang Chen et al. · British Journal of Clinical Pharmacology · 2012 · 184 citations · Full text

Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans

Stephen Castellino, Lee Moss, David S. Wagner et al. · Antimicrobial Agents and Chemotherapy · 2013 · 136 citations · Full text

, , +12

Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms

Adrian H. Chester, Canwen Jiang, Julie Borland et al. · Coronary Artery Disease · 1995 · 121 citations

Rows per page

1–5 of 43